drugset / Trial / NCT04240158
IW-6463 Safety Study in Healthy Elderly Subjects
RandomizedCrossoverTriple-blindTreatment
Summary
This is a randomized, double-blind, placebo-controlled, 2-way cross-over study in healthy male and female elderly participants.
Timeline
- Start
- 2020-01-06
- Primary completion
- 2020-05-22
- Completion
- 2020-05-22
Outcome
Outcome not reported
Stopped: “Some subjects could not complete the second crossover period due to COVID-19-related site closure. The study was closed to allow analysis of all collected data.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | zagociguat | Small molecule | — | Oral |
Indications
No indication recorded.